Company to host conference call and webcast on Thursday, May 14 at 8:30 am EDT LYON, France , May 6, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2020 after the

Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s

Maintains strong balance sheet with EUR 18.5 million ( USD 20.3 million ) in cash as of March 31, 2020 Signs exclusive worldwide distribution agreement with Exact Imaging to combine their innovative micro-ultrasound technology with Focal One to offer an end-to-end focal therapy solution for the

Seasoned medical technology sales and marketing professional brings more than 25 years of experience to the EDAP team Joins EDAP from Exact Imaging to lead the recently announced global distribution agreement between the two companies LYON, France , May 28, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the

  Appointment adds significant medical technology executive and board leadership experience LYON, France , June 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today that veteran medical technology executive Marie Meynadier has

Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solution Company recorded an additional three stand-alone ExactVu purchase orders at major centers LYON, France , July 15, 2020 -- EDAP TMS SA (Nasdaq:

  Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ultrasound therapy to treat prostate cancer patients since FDA cleared the technology in 2015.

Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDT LYON, France , August 19, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter ended June 30, 2020 after the

Multicenter study to commence in September in France Reinforces company’s recent shift in strategic focus toward development of additional high-value HIFU tissue ablation indications LYON, France , August 25, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic

Completed multiple Focal One sales to renowned U.S. and international health care institutions, including multiple Focal One™-ExactVu™ bundled sales Announced first two U.S. publications in Journal of Urology detailing positive outcomes from U.S. studies of HIFU for the successful partial-gland